Hosted by Dr. Jake Chen · 🇺🇸 US · EN-US · 62 episodes
Established thought leaders with verified media credentials.
Late-breaking advances in AI-enabled drug discovery, including news, research progress, market trends, and interviews
Dr. Jake Chen hosts Drug Discovery AI Talk, a news show with 62 episodes published.
This podcast explores the transformative shift toward New Approach Methodologies (NAMs), which utilize human-relevant experimental and computational systems to modernize drug discovery and biomedical research. Major fede
In this episode, we investigate the significant evolution of AI-driven toxicity prediction, detailing how the field has shifted from simple statistical models to sophisticated deep learning and multimodal systems. It hig
In this episode, Dr. Jake Chen provides his narrative review and advocates for a fundamental shift in pharmaceutical research, moving away from inefficient trial-and-error toward an AI-augmented scientific discipline. Th
Welcome to today's episode, where we dive into a monumental breakthrough in oncology, i.e., cracking the "undruggable" KRAS mutation. For decades, pancreatic cancer has been notoriously lethal, with few treatment options
AI isn't replacing scientists in the lab — it's joining the team. This episode unpacks "capability complementarity," the framework where human creativity and contextual judgment fuse with AI's speed and scale to crack pr
In this episode, we explore the evolution of leadership within the field of AI-driven drug discovery, identifying key figures who are reshaping how medicines are developed. It categorizes these "mavericks" into distinct
These sources present a framework for transitioning from vague notions of "trusting" artificial intelligence in drug discovery toward a more rigorous system of calibrated reliance. Both documents emphasize that AI reliab
In this episode, we explore the unique ethical landscape of AI-driven drug discovery, which extends beyond traditional data privacy to encompass the entire pharmaceutical lifecycle. Key challenges include algorithmic bia
In this episode, we explore the evolving landscape of AI-driven pharmaceutical intellectual property, emphasizing that, for patent offices, artificial intelligence is viewed as a computational tool rather than an invento
In this episode, we outline the critical role of biomarkers and companion diagnostics (CDx) in advancing personalized medicine and streamlining drug discovery. It details how germline genetic variations help prevent adve
Is AI drug discovery finally becoming investable, not just imaginable? In this episode, we unpack the blockbuster alliance between Insilico Medicine and Eli Lilly, including the eye-catching $115 million upfront payment
In this episode, we examine the transformative role of artificial intelligence in modern drug discovery and clinical trials, highlighting its potential to significantly shorten research timelines and reduce development c
In this episode, we explore OpenClaw, an open-source AI agent platform designed to function as an operational layer rather than a traditional chatbot within the biopharmaceutical industry. Instead of focusing on autonomo
In this episode, we discuss the 2026 AI-driven revolution in biotechnology, highlighting IsoDDE as a breakthrough tool for atomic-level drug design and protein interaction. This engine surpasses previous models, such as
This episode examines a bold proposal for "pharmaceutical superintelligence": a fully autonomous, AI-driven pipeline that handles everything from target identification to clinical trial planning using a single plain-lang
In this episode, we survey the evolving landscape of virtual clinical trials (VCTs), also known as in silico trials, which leverage computational modeling and artificial intelligence to predict therapeutic outcomes and o
This episode explores the founding and evolution of Insilico Medicine, tracing the journey of its founder, Alex Zhavoronkov, from a mortality-obsessed computer scientist in Latvia to a pioneer in the AI drug discovery re
In this episode, we present a curated countdown of the ten most influential research papers published in 2025 regarding AI-driven drug discovery and computational biology. The collection highlights a significant transiti
In this episode, we'll introduce a new publication, DrugCLIP, a high-speed artificial intelligence framework designed to revolutionize drug discovery through genome-wide virtual screening. This innovative method utilizes
In this episode, we provide a comprehensive overview of how AI is fundamentally transforming the field of drug delivery. The source material details advancements across numerous therapeutic modalities, including nanopart
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Drug Discovery AI Talk has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their news audience.
Drug Discovery AI Talk is hosted by Dr. Jake Chen. The show is categorised under news and has published 62 episodes.
Drug Discovery AI Talk has published 62 episodes.
Drug Discovery AI Talk regularly covers news. It sits in the news category.
Drug Discovery AI Talk is accessible for guests with genuine news expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Drug Discovery AI Talk hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Drug Discovery AI Talk average 20 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Drug Discovery AI Talk's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 4 days ago.
